Subscribe: Market Wire - Medical and Healthcare: Dentistry
http://img.marketwire.com/rss/mwMHDE.rss
Preview: Market Wire - Medical and Healthcare: Dentistry

Marketwired - Dentistry



Marketwired - Dentistry



Last Build Date: Thu, 17 Aug 2017 13:21:50 EDT

Copyright: Copyright: (C) Marketwired
 



Medovex Corporation Names Charlie Farrahar Chief Financial Officer

Thu, 17 Aug 2017 12:50:00 EDT

ATLANTA, GA--(Marketwired - Aug 17, 2017) - Medovex Corp. (NASDAQ: MDVX) ("Medovex" or the "Company"), the developer of the DenerveXT System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today reported it has named Charlie Farrahar as its Chief Financial Officer.




HealthDatix initiates pilot program with West Florida Health Network

Thu, 17 Aug 2017 11:48:19 EDT

SMITHTOWN, NY--(Marketwired - Aug 17, 2017) -  iGambit Inc. (OTCQB: IGMB) is pleased to announce that the company's wholly owned subsidiary, HealthDatix, Inc. has entered into a pilot program with West Florida Health Network (WFHN), which is a Community Integrated Network (CIN).




Kelly Hoover Thompson Joins the Strategic Health Information Exchange Collaborative (SHIEC) as CEO

Thu, 17 Aug 2017 09:00:00 EDT

Nationwide Consortium of HIEs to Benefit from New Leader's Broad Experience Ranging from Health IT Legislation to Implementing Real-world Health Data Exchange Solutions




Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

Wed, 16 Aug 2017 10:34:37 EDT

TORONTO, ON--(Marketwired - Aug 16, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of a 135-acre fully owned parcel of land for the cultivation, production and sale of medical / recreational marijuana to the cannabis industry and towards other revenue producing businesses.




Zynerba Failure Highlights the Need for Expertise, Broader Portfolios -- SECFilings.com

Tue, 15 Aug 2017 09:00:00 EDT

REDONDO BEACH, CA--(Marketwired - Aug 15, 2017) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article covering AXIM® Biotechnologies Inc.'s. (OTCQB: AXIM) clinical progress and broad portfolio in light of Zynerba's recent Phase II cannabidiol (CBD) gel patch failure.




CURE Pharma Could Take Over Where Zynerba Fell Short -- CFN Media

Fri, 11 Aug 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Aug 11, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing CURE Pharmaceutical Holding Corp.(OTCQB: CURR) and its development of an oral thin film drug delivery solution that could succeed where Zynerba Pharmaceuticals' cannabidiol gel system recently failed to meet clinical endpoints.




Fennec Provides Corporate Update and Announces Second Quarter 2017 Results

Fri, 11 Aug 2017 06:00:00 EDT

- SIOPEL 6 Results expected Q4 2017

- $7.6 million financing led by VENBIO Select Advisor in June 2017